India to Sri Lanka: Gliclazide Export Trade Route

The India to Sri Lanka Gliclazide corridor is one of India's established pharmaceutical export routes, with 314 shipments documented worth a combined $5.9M USD. The route is dominated by WALLACE PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 17% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.

Across 28 active suppliers, the average shipment value stands at $18.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with gliclazide's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 14.4%, placing it at rank #14 among India's top gliclazide export destinations globally.

On the import side, key buyers of Indian gliclazide in Sri Lanka include STATE PHARMACEUTICALS CORPORATION O, STATE PHARMACEUTICALS CORPORATION O , NA and 65 others. STATE PHARMACEUTICALS CORPORATION O is the single largest importer with 5 shipments valued at $674.7K USD.

India's gliclazide exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. WALLACE PHARMACEUTICALS PRIVATE LIMITED with 13 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 28 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — WALLACE PHARMACEUTICALS PRIVATE LIMITED, MICRO LABS LIMITED, IPCA LABORATORIES LIMITED — together account for 38% of total trade value on this route. The average shipment value of $18.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as glix mr 60 tablets gliclazide modified release tablets b p 60mg unit pack 10x10 s and 63987 packs of gliclazide modified release tablets b p 30 mg unit pack 10x10 s, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STATE PHARMACEUTICALS CORPORATION O is the largest importer with 5 shipments worth $674.7K USD — representing 11% of all gliclazide imports from India on this route. A total of 68 buyers are active on this corridor.